Biotechnology— SEC Filing Activity & Signals
119 biotechnology companies tracked above the $50M floor. In the last 90 days: 57 red 8-Ks, 0 insider cluster-buys, and 8 names running hot in the press. Sector 5-day move averages +7.39%.
119
Companies
57
Red 8-Ks · 90d
0
Insider clusters
8
🔥 Media-hot
WithinAllPharmaceuticals · 324Medical Devices · 134Biotechnology · 119Healthcare Services · 75Diagnostics & Tools · 27
All Biotechnology companies
Open in Search →| # | Ticker | Company | Mkt cap | 1D | 5D | Volume | Heat | Signals |
|---|---|---|---|---|---|---|---|---|
| 1 | AMGN | AMGEN INC | $191.7B | +0.4% | +4.3% | 2.2M | 🔥 | red 8-K |
| 2 | GILD | GILEAD SCIENCES, INC. | $155.9B | +0.0% | +1.0% | 7.4M | 🔥 | |
| 3 | ARGX | ARGENX SE | $55.6B | +1.7% | +8.7% | 359K | — | |
| 4 | IQV | IQVIA HOLDINGS INC. | $30.3B | -0.0% | +12.8% | 1.4M | ⚡ | red 8-K |
| 5 | BIIB | BIOGEN INC. | $29.5B | -0.3% | +9.6% | 1.1M | — | |
| 6 | BNTX | BioNTech SE | $22.9B | -1.3% | +2.7% | 561K | — | |
| 7 | INCY | INCYTE CORP | $21.7B | -1.1% | +8.6% | 1.8M | ⚡ | |
| 8 | MRNA | Moderna, Inc. | $19.8B | +0.5% | +14.8% | 11.8M | 🔥 | |
| 9 | NBIX | NEUROCRINE BIOSCIENCES INC | $16.1B | -0.9% | +4.4% | 1.1M | — | red 8-K |
| 10 | EXEL | EXELIXIS, INC. | $13.4B | +0.2% | +6.0% | 2.6M | — | red 8-K |
| 11 | MEDP | Medpace Holdings, Inc. | $13.3B | -1.0% | +11.8% | 336K | — | red 8-K |
| 12 | ICLR | ICON PLC | $11.2B | +0.4% | +21.8% | 1.1M | ⚡ | |
| 13 | KRYS | Krystal Biotech, Inc. | $9.4B | -1.7% | +9.3% | 309K | ⚡ | |
| 14 | CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | $9.0B | +0.5% | +21.5% | 1.1M | 🔥 | red 8-K |
| 15 | TECH | BIO-TECHNE Corp | $8.5B | -0.3% | +25.6% | 15.9M | 🔥 | red 8-K |
| 16 | HALO | HALOZYME THERAPEUTICS, INC. | $8.2B | +1.4% | +12.4% | 2.0M | — | red 8-K |
| 17 | QGEN | QIAGEN N.V. | $7.6B | -1.7% | +5.1% | 2.5M | — | |
| 18 | IBRX | ImmunityBio, Inc. | $7.4B | -0.2% | +19.6% | 9.3M | — | |
| 19 | RGEN | REPLIGEN CORP | $7.4B | -0.4% | +8.0% | 1.1M | — | |
| 20 | KYMR | Kymera Therapeutics, Inc. | $7.1B | +4.9% | +16.7% | 1.1M | 🔥 | red 8-K |
| 21 | IMVT | Immunovant, Inc. | $6.9B | +0.1% | +2.4% | 1.4M | — | |
| 22 | PCVX | Vaxcyte, Inc. | $6.9B | +0.7% | +11.9% | 2.5M | — | red 8-K |
| 23 | APGE | Apogee Therapeutics, Inc. | $6.7B | +0.1% | -0.1% | 5.4M | 🔥 | red 8-K |
| 24 | SRRK | Scholar Rock Holding Corp | $5.3B | +0.1% | +7.3% | 1.7M | — | |
| 25 | CGON | CG Oncology, Inc. | $5.3B | -3.6% | +8.1% | 1.4M | — | red 8-K |
| 26 | CRSP | CRISPR Therapeutics AG | $4.9B | -3.2% | +1.0% | 1.2M | ⚡ | red 8-K |
| 27 | TWST | Twist Bioscience Corp | $4.7B | +4.6% | +21.0% | 2.0M | — | |
| 28 | DNLI | Denali Therapeutics Inc. | $3.4B | -0.7% | +3.8% | 2.0M | — | |
| 29 | RLAY | Relay Therapeutics, Inc. | $3.2B | -5.2% | +7.3% | 5.8M | — | |
| 30 | BEAM | Beam Therapeutics Inc. | $3.0B | -1.8% | +3.4% | 1.7M | — | |
| 31 | ADPT | Adaptive Biotechnologies Corp | $2.8B | +0.2% | +24.5% | 3.8M | — | |
| 32 | TARS | Tarsus Pharmaceuticals, Inc. | $2.7B | +2.7% | -4.9% | 1.4M | — | |
| 33 | BCRX | BIOCRYST PHARMACEUTICALS INC | $2.2B | +4.7% | +7.4% | 7.7M | — | red 8-K |
| 34 | KOD | Kodiak Sciences Inc. | $2.1B | +3.2% | +5.2% | 1.5M | — | |
| 35 | VCEL | Vericel Corp | $1.9B | -1.3% | +10.2% | 743K | — | |
| 36 | ADMA | ADMA BIOLOGICS, INC. | $1.9B | 0.0% | -3.7% | 2.8M | — | |
| 37 | IOVA | IOVANCE BIOTHERAPEUTICS, INC. | $1.8B | -1.2% | -6.3% | 10.3M | — | |
| 38 | RXRX | RECURSION PHARMACEUTICALS, INC. | $1.7B | -0.5% | +16.1% | 23.2M | — | red 8-K |
| 39 | TSHA | Taysha Gene Therapies, Inc. | $1.6B | +1.2% | -0.7% | 6.7M | — | |
| 40 | GLUE | Monte Rosa Therapeutics, Inc. | $1.5B | +1.3% | +16.9% | 2.3M | — | |
| 41 | IMCR | Immunocore Holdings plc | $1.5B | +4.4% | +8.7% | 615K | — | |
| 42 | NVAX | NOVAVAX INC | $1.5B | +0.6% | +4.7% | 4.0M | — | |
| 43 | VIR | Vir Biotechnology, Inc. | $1.5B | -1.8% | +0.3% | 1.7M | — | red 8-K |
| 44 | INBX | Inhibrx Biosciences, Inc. | $1.4B | -0.8% | +2.0% | 218K | — | |
| 45 | MAZE | Maze Therapeutics, Inc. | $1.3B | +2.9% | +13.0% | 653K | — | red 8-K |
| 46 | IMTX | Immatics N.V. | $1.3B | +6.0% | +2.2% | 754K | — | |
| 47 | COAG | Hemab Therapeutics Holdings, Inc. | $1.2B | 0.0% | +26.0% | 322K | — | red 8-K |
| 48 | ABSI | Absci Corp | $1.1B | +2.1% | +56.4% | 5.8M | — | |
| 49 | MGTX | MeiraGTx Holdings plc | $888.1M | +7.7% | +14.4% | 1.8M | — | |
| 50 | CGEM | Cullinan Therapeutics, Inc. | $842.0M | -1.1% | +2.6% | 626K | — |